| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL PAPER |
Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Correspondence: Barrie R. Cassileth, Ph.D., Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, H13, New York, New York 10021, USA. Telephone: 212-639-8629; Fax: 212-794-5851; e-mail: Cassileth{at}mskcc.org
Many cancer patients use therapies promoted as literal alternatives to conventional medical care. Such "alternative" modalities are unproven or were studied and found worthless. These can be harmful. An even greater proportion of cancer patients uses "complementary" therapies along with mainstream cancer treatment. Most are helpful adjunctive approaches that control symptoms and enhance quality of life. This review describes alternative as well as complementary therapies commonly used today by cancer patients. Herbal remedies also are discussed. Evidence regarding the efficacy and safety of complementary/alternative medicine (CAM) is reviewed, and implications for oncologists are discussed. To encourage open communication of CAM use by patients, oncologists should be knowledgeable about the most popular remedies and know where to find reliable information for themselves and for their patients.
This article has been cited by other articles:
![]() |
R. Ziegler and R. Grossarth-Maticek Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador) Evid. Based Complement. Altern. Med., April 11, 2008; (2008) nen025v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirai, K. Komura, A. Tokoro, T. Kuromaru, A. Ohshima, T. Ito, Y. Sumiyoshi, and I. Hyodo Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients Ann. Onc., January 1, 2008; 19(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ziegler Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials? Evid. Based Complement. Altern. Med., October 4, 2007; (2007) nem121v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Cassileth, G. E. Deng, J. E. Gomez, P. A. S. Johnstone, N. Kumar, and A. J. Vickers Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 340S - 354S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lev-ari, Y. Maimon, and N. Yaal-Hahoshen Long-term Survival of a Patient With Widespread Metastases From Epithelial Ovarian Carcinoma Receiving Mind-Body Therapies: Case Report and Review of the Literature. Integr Cancer Ther, December 1, 2006; 5(4): 395 - 399. [Abstract] [PDF] |
||||
![]() |
M. Carlsson, M. Arman, M. Backman, U. Flatters, T. Hatschek, and E. Hamrin A Five-year Follow-up of Quality of Life in Women with Breast Cancer in Anthroposophic and Conventional Care Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 523 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lana, L. R. Kogan, K. A. Crump, J. T. Graham, and N. G. Robinson The use of complementary and alternative therapies in dogs and cats with cancer. J. Am. Anim. Hosp. Assoc., September 1, 2006; 42(5): 361 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Svatek, J. J. Lee, C. G. Roehrborn, S. M. Lippman, and Y. Lotan The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1485 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence Oncologist, July 1, 2006; 11(7): 732 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, X.-O. Shu, Y.-T. Gao, H. Cai, M.-H. Tao, and W. Zheng Association of Ginseng Use with Survival and Quality of Life among Breast Cancer Patients Am. J. Epidemiol., April 1, 2006; 163(7): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Padayatty, H. D. Riordan, S. M. Hewitt, A. Katz, L. J. Hoffer, and M. Levine Intravenously administered vitamin C as cancer therapy: three cases. Can. Med. Assoc. J., March 28, 2006; 174(7): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-K. Hui, E. K. Hui, and M. F. Johnston The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-west medicine. Integr Cancer Ther, March 1, 2006; 5(1): 56 - 62. [Abstract] [PDF] |
||||
![]() |
D. M. Hann, F. Baker, C. S. Roberts, C. Witt, J. McDonald, M. Livingston, J. Ruiterman, R. Ampela, C. Crammer, and O. Kaw Use of Complementary Therapies Among Breast and Prostate Cancer Patients During Treatment: A Multisite Study Integr Cancer Ther, December 1, 2005; 4(4): 294 - 300. [Abstract] [PDF] |
||||
![]() |
D. Hann, F. Baker, M. Denniston, and N. Entrekin Long-term Breast Cancer Survivors' Use of Complementary Therapies: Perceived Impact on Recovery and Prevention of Recurrence Integr Cancer Ther, March 1, 2005; 4(1): 14 - 20. [Abstract] [PDF] |
||||
![]() |
D. S. Rosenthal and E. Dean-Clower Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies Hematology, January 1, 2005; 2005(1): 491 - 497. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |